Olfr690 Inhibitors

Olfr690, encoded by the Or52b1 gene, is an olfactory receptor in Mus musculus and a member of the G-protein-coupled receptor (GPCR) superfamily. These receptors are vital for the sense of smell, detecting odorant molecules in the nasal epithelium and initiating neuronal responses that lead to olfactory perception. Olfactory receptors like Olfr690 share a 7-transmembrane domain structure, common to many neurotransmitter and hormone receptors. They are responsible for the recognition and G protein-mediated transduction of odorant signals. The activation of these receptors by specific odorants triggers various intracellular events, often involving the modulation of second messengers such as cyclic AMP (cAMP).

Given the complexity of GPCR signaling pathways and the lack of well-characterized direct inhibitors, the focus is on potential indirect inhibitors that modulate related signaling pathways or cellular processes. Beta-adrenergic receptor antagonists, such as propranolol, atenolol, and metoprolol, reduce cellular cAMP levels, a critical component in GPCR signaling. This reduction in cAMP may indirectly affect the signaling pathways of GPCRs, potentially altering the function of olfactory receptors like Olfr690. Calcium channel blockers, such as nifedipine and verapamil, alter intracellular calcium levels, another key factor in GPCR signaling. These changes in calcium dynamics can indirectly influence the function of GPCRs, including olfactory receptors.